Merck & Company Common Stock
(New)
   

Merck ( MRK) Stock Price

Merck stock quote | Merck company information | Merck Stock Chart | Merck Stock News

Company Description : Merck & Co., Inc. is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. url: www.merck.com

Name:
Merck & Company Common Stock (New)		 Symbol:
NYSE:MRK		 Stock Market:
New York Stock Exchange		 Type:
Equity		 ISIN:
US58933Y1055		 Description:
 ChangeChange %CurBidAskHighLowOpenVolumeTimeA
-0.176-0.4737.64537.8937.5937.73375228612:10:13
stock Prices on this screen are 15 minutes delayed

FDA Approves New Labeling for ISENTRESS® (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety & T...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved a labeling update for ISENTRESS® (raltegravir) Film-coated Tablets to include 156-week data from the STARTMRK study with ISENTRESS in combination therapy compared to efavirenz in combination...

Free Merck Stock Charts

Merck Historical Stock Chart
Merck Historical Stock Chart
Merck Monthly Stock Chart
Merck Monthly Stock Chart		Merck Intraday stock chart
Merck Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Delta Weighted Moving Average and ZigZag.

Get the Latest Merck stock Price, quotes, trades and FREE Merck stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Merck (MRK) and other New York Stock Exchange listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Merck News & Message Board Discussion

Latest Merck News Headlines
DateTimeSource
HeadlineMore MRK News
05/21/20128:00AMBWFDA Approves New Labeling for ISENTRESS® (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety & T...
05/16/20128:00AMBWMerck to Present at Bank of America Merrill Lynch 2012 Healthcare Conference
05/10/20123:08PMEDGARStatement of Changes in Beneficial Ownership
05/10/20125:15AMZACKSSimcere Misses on all Fronts - Analyst Blog
05/08/20129:37AMDJNWSJ BLOG/Health: A.M Vitals: "Good" Cholesterol Drug Fails; Alzheimer's and Depression Linked
05/08/20128:00AMBWMerck to Present at Deutsche Bank 37th Annual Health Care Conference
05/08/20127:42AMEDGARQuarterly Report
05/07/20124:45PMDJN2nd UPDATE: Abbott To Pay $1.6 Billion To Settle Depakote Marketing Probes
05/04/201212:35PMDJNHouse Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg
05/04/20129:43AMEDGARStatement of Changes in Beneficial Ownership
05/04/20129:43AMEDGARStatement of Changes in Beneficial Ownership
05/04/20129:42AMEDGARStatement of Changes in Beneficial Ownership

Merck Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Merck company information and fundamental data for other USA Equity companies. More than 100 separate statistics including assets turnover and net working capital ratio.

Latest Merck Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  100 37.645 05/21/2012 12:10PM USD


 



Merck Stock Prices supplied by NYSE.
Free NYSE stock prices are delayed by at least 15 minutes. Realtime NYSE stock prices available.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Affiliate Scheme
Copyright 1999-2011 ADVFN PLC. Copyright Notice & Privacy Policy :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
43 site:2us nyse mrk120521 12:25